Blog ITS World Congress 2008 in NYC

On Sunday, the 2008 ITS World Congress kicked-off its biggest event ever in NYC. Guests were treated to a top-notch opening ceremony that miraculously managed to fit in half a dozen speakers and artistic performances ranging from hip hop to opera, violins, ballet and Broadway favorites.
New York City has closed down and renamed 11th Ave. in front of the convention center (name is now ITS World Congress Blvd.) for demonstrations of exotic technologies such as automatic collision avoidance and driverless autonomous vehicles.

Mercedes-Benz revealed their “Mindlab” technology – a method they developed to measure the driver’s brainwaves as they drive. The technology is so new it hasn’t even made it into their advanced F700 research vehicle yet.
New York City will also be showing off their Joint Traffic Transportation Management Center, which among other great achievements, now wirelessly controls 12,000 intersections in real time.
The global cadre of ITS experts now face the daunting task of taking in the staggering amount of information presented in 300,000 square feet of space and four full days of sessions.


MTV’s Total Request Live Finale

Fall Out Boy at MTV’s TRL Finale

After the opening ceremony, a few of the more energetic participants took to Times Square to witness a dubious American icon (MTV) film the finale of its TRL event live featuring the likes of Beyonce, Justin Timberlake, N’Sync, P Diddy, 50 Cent, Ludacris, Nelly and of course the immortal Snoop Dogg. Sadly, where as the ITS congress planners managed to fit five brilliant acts in about an hour, MTV did live as it does on the air – mostly waste time and play as little music as possible. Such is life…
Stay tuned as I cover the juiciest techie details this week with a focus on traffic signal optimization, and ITS and the environment.

Matthew Scholz

Matt is Chief Executive Officer and co-founder of Oisín Bio. A serial entrepreneur with a background in computer security and immunology, Matt is also the founder and CEO of Immusoft, a biotech firm developing a breakthrough technology that will turn a patient's B cells into miniature drug factories. Matthew speaks and presents regularly to university, association and scientific audiences, including those at his alma mater, the University of Washington. He served for several years as a mentor to recipients of the Thiel Fellowship, a program that awarded grants to some of the world’s brightest scientific minds under age 20.